Clinical effects of permanent pacemaker implantation after transcatheter aortic valve implantation: Insights from the nationwide FRANCE-TAVI registry

Archive ouverte

Auffret, Vincent | Boulmier, Dominique | Didier, Romain | Leurent, Guillaume | Bedossa, Marc | Tomasi, Jacques | Cayla, Guillaume | Benamer, Hakim | Beurtheret, Sylvain | Verhoye, Jean-Philippe | Commeau, Philippe | Lefevre, Thierry | Iung, Bernard | Eltchaninoff, Helene | Collet, Jean-Philippe | Dumonteil, Nicolas | Du Chayla, Florence | Gouysse, Margaux | Gilard, Martine | Le Breton, Hervé

Edité par CCSD ; Elsevier ; Société française de cardiologie [2008-....] -

International audience. BackgroundThe influence of permanent pacemaker implantation upon outcomes after transcatheter aortic valve implantation (TAVI) remains controversial.AimsTo evaluate the impact of permanent pacemaker implantation after TAVI on short- and long-term mortality, and on the risk of hospitalization for heart failure.MethodsData from the large FRANCE-TAVI registry, linked to the French national health single-payer claims database, were analysed to compare 30-day and long-term mortality rates and hospitalization for heart failure rates among patients with versus without permanent pacemaker implantation after TAVI. Multivariable regressions were performed to adjust for confounders.ResultsA total of 36,549 patients (mean age 82.6 years; 51.6% female) who underwent TAVI from 2013 to 2019 were included in the present analysis. Among them, 6999 (19.1%) received permanent pacemaker implantation during the index hospitalization, whereas 232 (0.6%) underwent permanent pacemaker implantation between hospital discharge and 30 days after TAVI, at a median of 11 (interquartile range: 7–18) days. In-hospital permanent pacemaker implantation was not associated with an increased risk of death between discharge and 30 days (adjusted odds ratio: 0.91, 95% confidence interval: 0.64–1.29). At 5 years, the incidence of all-cause death was higher among patients with versus without permanent pacemaker implantation within 30 days of the procedure (adjusted hazard ratio: 1.13, 95% confidence interval: 1.07–1.19). Permanent pacemaker implantation within 30 days of TAVI was also associated with a higher 5-year rate of hospitalization for heart failure (adjusted subhazard ratio: 1.17, 95% confidence interval: 1.11–1.23).ConclusionsPermanent pacemaker implantation after TAVI is associated with an increased risk of long-term hospitalization for heart failure and all-cause mortality. Further research to mitigate the risk of postprocedural permanent pacemaker implantation is needed as TAVI indications expand to lower-risk patients.

Suggestions

Du même auteur

Long-Term Prognosis Value of Paravalvular Leak and Patient–Prosthesis Mismatch following Transcatheter Aortic Valve Implantation: Insight from the France-TAVI Registry

Archive ouverte | Deharo, Pierre | CCSD

International audience. Background: Transcatheter aortic valve implantation (TAVI) is the preferred treatment for symptomatic severe aortic stenosis (AS) in a majority of patients across all surgical risks. Patients...

Predictors of Outcomes of Reintervention After Transcatheter Aortic Valve Replacement

Archive ouverte | Durand, Eric | CCSD

International audience. Background: In a context of extending transcatheter aortic valve replacement (TAVR) to patients with a longer life expectancy, it is important to better document the incidence and outcomes of...

Evolution of TAVI patients and techniques over the past decade: The French TAVI registries

Archive ouverte | Didier, Romain | CCSD

International audience. Background. - The French transcatheter aortic valve implantation (TAVI) registries, linked with the nationwide administrative databases, have collected data on TAVI procedures from the first ...

Chargement des enrichissements...